Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Opioid-Induced Constipation market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 13.0% during the forecast period.
This report presents the market size and development trends by detailing the Opioid-Induced Constipation market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Opioid-Induced Constipation market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Opioid-Induced Constipation industry and will help you to build a panoramic view of the industrial development.
Opioid-Induced Constipation Market, By Type:
Oral
Parenteral
Opioid-Induced Constipation Market, By Application:
End-User 1
End-User 2
End-User 3
Some of the leading players are as follows:
Johnson & Johnson
Pfizer
Shionogi
Mundipharma
Boehringer Ingelheim
Synergy Pharmaceuticals
Nektar Therapeutics
SLA Pharma
Valeant Pharmaceuticals International
Cosmo Pharmaceuticals
Takeda Pharmaceutical
Progenics Pharmaceuticals
Theravance
C.B. Fleet
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Opioid-Induced Constipation Market: Technology Type Analysis
-
4.1 Opioid-Induced Constipation Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Opioid-Induced Constipation Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Oral
4.3.2 Parenteral
5 Opioid-Induced Constipation Market: Product Analysis
-
5.1 Opioid-Induced Constipation Product Market Share Analysis, 2018 & 2026
-
5.2 Opioid-Induced Constipation Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Opioid-Induced Constipation Market: Application Analysis
-
6.1 Opioid-Induced Constipation Application Market Share Analysis, 2018 & 2026
-
6.2 Opioid-Induced Constipation Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 End-User 1
6.3.2 End-User 1
6.3.3 End-User 3
7 Opioid-Induced Constipation Market: Regional Analysis
-
7.1 Opioid-Induced Constipation Regional Market Share Analysis, 2018 & 2026
-
7.2 Opioid-Induced Constipation Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Johnson & Johnson
9.1.1 Johnson & Johnson Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Pfizer
9.2.1 Pfizer Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Shionogi
9.3.1 Shionogi Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Mundipharma
9.4.1 Mundipharma Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Boehringer Ingelheim
9.5.1 Boehringer Ingelheim Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Synergy Pharmaceuticals
9.6.1 Synergy Pharmaceuticals Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Nektar Therapeutics
9.7.1 Nektar Therapeutics Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 SLA Pharma
9.8.1 SLA Pharma Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Valeant Pharmaceuticals International
9.9.1 Valeant Pharmaceuticals International Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Cosmo Pharmaceuticals
9.10.1 Cosmo Pharmaceuticals Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Takeda Pharmaceutical
9.11.1 Takeda Pharmaceutical Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Progenics Pharmaceuticals
9.12.1 Progenics Pharmaceuticals Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Theravance
9.13.1 Theravance Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 C.B. Fleet
9.14.1 C.B. Fleet Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
The List of Tables and Figures (Totals 87 Figures and 130 Tables)
Figure Oral Opioid-Induced Constipation market, 2015 - 2026 (USD Million)
Figure Parenteral Opioid-Induced Constipation market, 2015 - 2026 (USD Million)
Figure End-User 1 market, 2015 - 2026 (USD Million)
Figure End-User 2 market, 2015 - 2026 (USD Million)
Figure End-User 3 market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Opioid-Induced Constipation market, by country, 2015 - 2026 (USD Million)
-
Table North America Opioid-Induced Constipation market, by type, 2015 - 2026 (USD Million)
-
Table North America Opioid-Induced Constipation market, by product, 2015 - 2026 (USD Million)
-
Table North America Opioid-Induced Constipation market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Opioid-Induced Constipation market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Opioid-Induced Constipation market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Opioid-Induced Constipation market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Opioid-Induced Constipation market, by type, 2015 - 2026 (USD Million)
-
Table Canada Opioid-Induced Constipation market, by product, 2015 - 2026 (USD Million)
-
Table Canada Opioid-Induced Constipation market, by application, 2015 - 2026 (USD Million)
-
Table Europe Opioid-Induced Constipation market, by country, 2015 - 2026 (USD Million)
-
Table Europe Opioid-Induced Constipation market, by type, 2015 - 2026 (USD Million)
-
Table Europe Opioid-Induced Constipation market, by product, 2015 - 2026 (USD Million)
-
Table Europe Opioid-Induced Constipation market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Opioid-Induced Constipation market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Opioid-Induced Constipation market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Opioid-Induced Constipation market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Opioid-Induced Constipation market, by type, 2015 - 2026 (USD Million)
-
Table Germany Opioid-Induced Constipation market, by product, 2015 - 2026 (USD Million)
-
Table Germany Opioid-Induced Constipation market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Opioid-Induced Constipation market, by type, 2015 - 2026 (USD Million)
-
Table France Opioid-Induced Constipation market, by product, 2015 - 2026 (USD Million)
-
Table France Opioid-Induced Constipation market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Opioid-Induced Constipation market, by type, 2015 - 2026 (USD Million)
-
Table Italy Opioid-Induced Constipation market, by product, 2015 - 2026 (USD Million)
-
Table Italy Opioid-Induced Constipation market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Opioid-Induced Constipation market, by type, 2015 - 2026 (USD Million)
-
Table Spain Opioid-Induced Constipation market, by product, 2015 - 2026 (USD Million)
-
Table Spain Opioid-Induced Constipation market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Opioid-Induced Constipation market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Opioid-Induced Constipation market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Opioid-Induced Constipation market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Opioid-Induced Constipation market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Opioid-Induced Constipation market, by type, 2015 - 2026 (USD Million)
-
Table China Opioid-Induced Constipation market, by product, 2015 - 2026 (USD Million)
-
Table China Opioid-Induced Constipation market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Opioid-Induced Constipation market, by type, 2015 - 2026 (USD Million)
-
Table Japan Opioid-Induced Constipation market, by product, 2015 - 2026 (USD Million)
-
Table Japan Opioid-Induced Constipation market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Opioid-Induced Constipation market, by type, 2015 - 2026 (USD Million)
-
Table India Opioid-Induced Constipation market, by product, 2015 - 2026 (USD Million)
-
Table India Opioid-Induced Constipation market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Opioid-Induced Constipation market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Opioid-Induced Constipation market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Opioid-Induced Constipation market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Opioid-Induced Constipation market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Opioid-Induced Constipation market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Opioid-Induced Constipation market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Opioid-Induced Constipation market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Opioid-Induced Constipation market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Opioid-Induced Constipation market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Opioid-Induced Constipation market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Opioid-Induced Constipation market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Opioid-Induced Constipation market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Opioid-Induced Constipation market, by application, 2015 - 2026 (USD Million)
-
Table MEA Opioid-Induced Constipation market, by country, 2015 - 2026 (USD Million)
-
Table MEA Opioid-Induced Constipation market, by type, 2015 - 2026 (USD Million)
-
Table MEA Opioid-Induced Constipation market, by product, 2015 - 2026 (USD Million)
-
Table MEA Opioid-Induced Constipation market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Opioid-Induced Constipation market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Opioid-Induced Constipation market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Opioid-Induced Constipation market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Opioid-Induced Constipation market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Opioid-Induced Constipation market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Opioid-Induced Constipation market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Shionogi Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mundipharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Synergy Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Nektar Therapeutics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table SLA Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Valeant Pharmaceuticals International Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cosmo Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Takeda Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Progenics Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Theravance Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table C.B. Fleet Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
